Cincinnati Financial Corp (NASDAQ: CINF) has reported earnings for its second fiscal quarter (ending June 30) of $1.99 versus $3.40 for the same period a year ago — a decline of -41%. However, this result […]
Celldex Therapeutics Inc (NASDAQ: CLDX) stock enjoyed a major increase of 11.6% on 7/25/24. The shares closed at $43.86. Moreover, trading volume in this advance was unusually high at 157% of normal. The stock has […]
Carter Bankshares Inc (NASDAQ: CARE) has reported E.P.S. of $0.21 for its second fiscal quarter (ending June 30) versus $0.24 for the same period a year ago — a decline of -12%. Relative to the […]
For its second fiscal quarter (ending June 30), CVB Financial Corp (NASDAQ: CVBF) has reported a -10% decline in E.P.S. from $0.40 a year ago to $0.36 in the current quarter. However, this performance was […]
Visteon Corp. (NASDAQ: VC) has reported E.P.S. of $2.57 for its second fiscal quarter (ending June 30) versus $0.71 for the same period a year ago — an increase of 262%. Relative to the consensus […]
Verisign Inc (NASDAQ: VRSN) has reported earnings for its second fiscal quarter (ending June 30) of $2.01 versus $1.79 for the same period a year ago — an increase of 12%. Relative to the consensus […]
Texas Roadhouse Inc (NASDAQ: TXRH) has reported E.P.S. of $1.80 for its second fiscal quarter (ending June 30) versus $1.23 for the same period a year ago — an increase of 46%. Relative to the […]
Southside Bancshares Inc (NASDAQ: SBSI) has reported E.P.S. of $0.81 for its second fiscal quarter (ending June 30) versus $0.81 for the same period a year ago — flat performance. Relative to the consensus estimate […]
MaxLinear Inc (NASDAQ: MXL) stock closed at $14.02 on 7/25/24 after a major decline of -37.1%. Moreover, exceptionally high trading volume at 865% of normal accompanied the decline. The stock has declined -44.8% during the […]
LPL Financial Holdings Inc (NASDAQ: LPLA) has reported E.P.S. of $3.26 for its second fiscal quarter (ending June 30) versus $3.70 for the same period a year ago — a decline of -12%. Relative to […]
Privacy Statement Terms Of Use ©2024 PriceTarget Research